Sophie Paget‐Bailly

Three Versus 6 Months of Oxaliplatin-Based Adjuvant Chemotherapy for Patients With Stage III Colon Cancer: Disease-Free Survival Results From a Randomized, Open-Label, International Duration Evaluation of Adjuvant (IDEA) France, Phase III Trial

Thierry André, Déwi Vernerey, Laurent Mineur et al. · Journal of Clinical Oncology · 2018 · 169 citations

Dfs Events, Surgical Oncology, Oncology +14

Time to health-related quality of life score deterioration as a modality of longitudinal analysis for health-related quality of life studies in oncology: do we need RECIST for quality of life to achieve standardization?

Amélie Anota, Zeinab Hamidou, Sophie Paget‐Bailly et al. · Quality of Life Research · 2013 · 125 citations · Full text

6 months versus 12 months of adjuvant trastuzumab in early breast cancer (PHARE): final analysis of a multicentre, open-label, phase 3 randomised trial

Xavier Pivot, Gilles Romieu, Marc Debled et al. · The Lancet · 2019 · 125 citations

Breast Oncology, Oncology, Early Breast Cancer +6

Tobacco smoking, alcohol drinking and risk of oral cavity cancer by subsite

Loredana Radoï, Sophie Paget‐Bailly, Diane Cyr et al. · European Journal of Cancer Prevention · 2012 · 99 citations

Prognostic nomogram and score to predict overall survival in locally advanced untreated pancreatic cancer (PROLAP)

Déwi Vernerey, F. Huguet, Angélique Vienot et al. · British Journal of Cancer · 2016 · 75 citations · Full text